Harrow HROW
NASDAQ HROW
$37.56 -0.29 (-0.77%)
As of: Sep 9, 2026 · 2:33 PM EDT

Harrow (HROW) Price to Earnings (2010 - 2026)

Harrow (HROW) posted Price to Earnings of 92.18 for Q2 2026, down 93.62% on a QoQ basis from 47.61 in Q1 2026, and down 141.06% year-over-year from 224.48 in Q2 2025.

Analysis

Harrow (HROW) Price to Earnings (2010 - 2026) Analysis & Trends

Harrow has reported Price to Earnings for 17 years, with the latest figure at 92.18 in Q2 2026.

  • On a quarterly basis, Price to Earnings fell 141.06% year-over-year to 92.18 in Q2 2026; TTM through Jun 2026 was 47.58, a 56.59% increase from a year earlier, with the FY2025 full-year figure at 354.98, down 419.22% from the prior year.
  • Price to Earnings was 92.18 for Q2 2026 at Harrow, down from 47.61 in the prior quarter.
  • The five-year high for Price to Earnings was 1749.34 in Q3 2025, with the low at 379.4 in Q3 2024.
  • Average Price to Earnings over 5 years is 81.92, with a median of 49.08 recorded in 2022.
  • The sharpest annual moves came in 2022 and 2023: Price to Earnings soared 1435.07% in 2022, then plunged 331.56% in 2023.
  • Over 5 years, Price to Earnings stood at 418.34 in 2022, then plunged by 110.29% to 43.06 in 2023, then soared by 509.57% to 176.35 in 2024, then dropped by 0.51% to 175.46 in 2025, then plunged by 152.54% to 92.18 in 2026.
  • The last three Price to Earnings figures came in at 92.18 (Q2 2026), 47.61 (Q1 2026), and 175.46 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.95 Bn 625.20 Bn 17.26 Bn
2 AbbVie 441.39 Bn 434.82 Bn 12.70 Bn
3 Merck 366.72 Bn 359.58 Bn 12.21 Bn
4 Novartis Ag 266.68 Bn 258.99 Bn 11.24 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.08 Bn 44.08 Bn -
8 Incyte 25.50 Bn 20.96 Bn 1.57 Bn
9 United Therapeutics 21.54 Bn 18.88 Bn 683.80 Mn
10 Harrow 1.40 Bn 1.32 Bn 50.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -92.18
Mar 31, 2026 -47.61
Dec 31, 2025 175.46
Sep 30, 2025 1,749.34
Jun 30, 2025 224.48
Mar 31, 2025 -53.34
Dec 31, 2024 176.35
Sep 30, 2024 -379.40
Jun 30, 2024 -114.50
Mar 31, 2024 -34.51
Dec 31, 2023 -43.06
Sep 30, 2023 -114.93
Jun 30, 2023 -136.31
Mar 31, 2023 -95.74
Dec 31, 2022 418.34
Sep 30, 2022 -50.55
Jun 30, 2022 -31.59
Mar 31, 2022 -75.62
Dec 31, 2021 -31.33
Sep 30, 2021 -29.36